Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Linyun Zhai
Mp20-11 the Diagnostic Efficacy of Biparametric Non-Contrast Mri in Patients With Total Prostate-Specific Antigen Level of 4-10 Ng/Ml: A Multi-Center Study
Journal of Urology
Urology
Related publications
Hormonal Study in Patients With Prostate Cancer With PSA at Diagnosis Between 4-10 Ng/Ml and PSA Free/Total <20%
ACTUALIDAD MEDICA
Assessment of the Relationship Between Serum Prostate-Specific Antigen Level and Serum Fasting Glucose, Total Cholesterol and Neutrophil-Lymphocyte Ratio in Men Aged 50-70 Years With Prostate-Specific Antigen Level 0-10 Ng/mL Without Prostate Cancer Diagnosis
Üroonkoloji Bülteni
Predictive Factors for Prostate Cancer in Biopsy of Patients With Prostate-Specific Antigen Levels Equal to or Less Than 4 Ng/Ml
Korean Journal of Urology
Urology
Prognosis of Prostate Cancer With Initial Prostate-Specific Antigen ≫1,000 Ng/mL at Diagnosis
OncoTargets and Therapy
Oncology
Pharmacology
Tumor Characteristics, Treatments, and Survival Outcomes in Prostate Cancer Patients With a PSA Level < 4 Ng/Ml: A Population-Based Study
BMC Cancer
Cancer Research
Oncology
Genetics
Long-Term Outcomes of Radical Prostatectomy With Multimodal Adjuvant Therapy in Men With a Preoperative Serum Prostate-Specific Antigen Level ≥50 Ng/mL
Cancer
Cancer Research
Oncology
Association of Nadir Prostate-Specific Antigen >0.5 Ng/mL After Dose-Escalated External Beam Radiation With Prostate Cancer-Specific Endpoints
Cureus
Lymphocyte-To-Monocyte Ratio Is a Valuable Marker to Predict Prostate Cancer in Patients With Prostate Specific Antigen Between 4 and 10 Ng/Dl
Archivio Italiano di Urologia Andrologia
Urology
Prevalence of Prostate Cancer Among Men With a Prostate-Specific Antigen Level ≤4.0 Ng Per Milliliter
New England Journal of Medicine
Medicine
